Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: REXTOVY
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 4MG/SPRAY
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208969
Product Number: 001
Approval Date: Mar 7, 2023
Applicant Holder Full Name: AMPHASTAR PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information